These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12952140)

  • 1. Delivery outcome after the use of meclozine in early pregnancy.
    Källén B; Mottet I
    Eur J Epidemiol; 2003; 18(7):665-9. PubMed ID: 12952140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antiemetic drugs during pregnancy in Sweden.
    Asker C; Norstedt Wikner B; Källén B
    Eur J Clin Pharmacol; 2005 Dec; 61(12):899-906. PubMed ID: 16328314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The perception of teratogenic risk by women with nausea and vomiting of pregnancy.
    Mazzotta P; Magee LA; Maltepe C; Lifshitz A; Navioz Y; Koren G
    Reprod Toxicol; 1999; 13(4):313-9. PubMed ID: 10453916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study.
    Berkovitch M; Mazzota P; Greenberg R; Elbirt D; Addis A; Schuler-Faccini L; Merlob P; Arnon J; Stahl B; Magee L; Moretti M; Ornoy A
    Am J Perinatol; 2002 Aug; 19(6):311-6. PubMed ID: 12357422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ondansetron during pregnancy and congenital malformations in the infant.
    Danielsson B; Wikner BN; Källén B
    Reprod Toxicol; 2014 Dec; 50():134-7. PubMed ID: 25450422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal use of antipsychotics in early pregnancy and delivery outcome.
    Reis M; Källén B
    J Clin Psychopharmacol; 2008 Jun; 28(3):279-88. PubMed ID: 18480684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of metoclopramide use in the first trimester of pregnancy.
    Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
    N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antihistamine drugs in early pregnancy and delivery outcome.
    Källén B
    J Matern Fetal Neonatal Med; 2002 Mar; 11(3):146-52. PubMed ID: 12380668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy.
    Leathem AM
    Clin Pharm; 1986 Aug; 5(8):660-8. PubMed ID: 2874910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cleft lip and palate associated with meclozine].
    Lastra-Lastra A; Sánchez-Hernandez J; Jiménez-Balderas EA
    Ginecol Obstet Mex; 1996 Nov; 64():485. PubMed ID: 9091423
    [No Abstract]   [Full Text] [Related]  

  • 11. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.
    Reis M; Källén B
    Psychol Med; 2010 Oct; 40(10):1723-33. PubMed ID: 20047705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between vitamin use, smoking, and nausea and vomiting of pregnancy.
    Källén B; Lundberg G; Aberg A
    Acta Obstet Gynecol Scand; 2003 Oct; 82(10):916-20. PubMed ID: 12956841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of drug therapy for nausea and vomiting of pregnancy.
    Huff PS
    J Fam Pract; 1980 Nov; 11(6):969-70. PubMed ID: 7005391
    [No Abstract]   [Full Text] [Related]  

  • 14. Bendectin and birth defects. II: Ecological analyses.
    Kutcher JS; Engle A; Firth J; Lamm SH
    Birth Defects Res A Clin Mol Teratol; 2003 Feb; 67(2):88-97. PubMed ID: 12769504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of drugs and pregnancy. II. Anti-emetic drugs.
    Kullander S; Källén B
    Acta Obstet Gynecol Scand; 1976; 55(2):105-11. PubMed ID: 943896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy complications and birth outcomes among women experiencing nausea only or nausea and vomiting during pregnancy in the Norwegian Mother and Child Cohort Study.
    Chortatos A; Haugen M; Iversen PO; Vikanes Å; Eberhard-Gran M; Bjelland EK; Magnus P; Veierød MB
    BMC Pregnancy Childbirth; 2015 Jun; 15():138. PubMed ID: 26100060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP).
    Magee LA; Mazzotta P; Koren G
    Am J Obstet Gynecol; 2002 May; 186(5 Suppl Understanding):S256-61. PubMed ID: 12011897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The teratogenicity of drugs for nausea and vomiting of pregnancy: perceived versus true risk.
    Koren G; Levichek Z
    Am J Obstet Gynecol; 2002 May; 186(5 Suppl Understanding):S248-52. PubMed ID: 12011895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of nausea and vomiting during pregnancy -a cross-sectional study among 712 Norwegian women.
    Heitmann K; Solheimsnes A; Havnen GC; Nordeng H; Holst L
    Eur J Clin Pharmacol; 2016 May; 72(5):593-604. PubMed ID: 26815908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical, social, and legal implications of treating nausea and vomiting of pregnancy.
    Brent R
    Am J Obstet Gynecol; 2002 May; 186(5 Suppl Understanding):S262-6. PubMed ID: 12011898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.